References
- P K D, Jeemon P, N K A, et al. Status of epidemiology in the WHO South-East Asia region: burden of disease, determinants of health and epidemiological research, workforce and training capacity. Int J Epidemiol. 2012;41(3):847–860.
- P J M, Lehrer DS, Vitamin D. cod liver oil, sunshine, and phototherapy: safe, effective and forgotten tools for treating and curing tuberculosis infections - a comprehensive review. J Steroid Biochem Mol Biol. 2018;177:21–29.
- Sgaragli G, Frosini M. Human tuberculosis I. epidemiology, diagnosis and pathogenetic mechanisms. Curr Med Chem. 2016;23(25):2836–2873.
- Subbian S, Bandyopadhyay N, Tsenova L, et al. Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits. Cell Commun Signal. 2013;11:60.
- Sabir N, Hussain T, S Z A S, et al. miRNAs in tuberculosis: new avenues for diagnosis and host-directed therapy. Front Microbiol. 2018;9:602.
- Nonghanphithak D, Reechaipichitkul W, Namwat W, et al. Genetic polymorphisms of CCL2 associated with susceptibility to latent tuberculous infection in Thailand. Int J Tuberc Lung Dis. 2016;20(9):1242–1248.
- C H L, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14(12):963–975.
- Shimizu T, Tomioka H. Novel type of antimicrobial mechanism in host macrophages against mycobacterial infections. Nihon Hansenbyo Gakkai Zasshi. 2009;78(3):283–291.
- A H M, Kornfeld H. Cell death and autophagy in tuberculosis. Semin Immunol. 2014;26(6):497–511.
- Yuan Y, Lin D, Feng L, et al. Upregulation of miR-196b-5p attenuates BCG uptake via targeting SOCS3 and activating STAT3 in macrophages from patients with long-term cigarette smoking-related active pulmonary tuberculosis. J Transl Med. 2018;16(1):284.
- Ma C, Li Y, Li M, et al. microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infection. Mol Immunol. 2014;62(1):150–158.
- Shen H, Gu J, Xiao H, et al. Selective destruction of interleukin 23-induced expansion of a major antigen-specific gammadelta T-cell subset in patients with tuberculosis. J Infect Dis. 2017;215(3):420–430.
- Wagh V, Urhekar A, Modi D. Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy. Tuberculosis (Edinb). 2017;102:24–30.
- Zhang C, C D Z, M H M, et al. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. World J Gastroenterol. 2018;24(11):1206–1215.
- L L M, W J W, Y T Q, et al. miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma. PLoS One. 2017;12(10):e0185636.
- Venkatadri R, Muni T, A K I, et al. Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death. Cell Death Dis. 2016;7:e2104.
- J H Y, Her S, Kim M, et al. The expression of damage-regulated autophagy modulator 2 (DRAM2) contributes to autophagy induction. Mol Biol Rep. 2012;39(2):1087–1093.
- O’Prey J, Skommer J, Wilkinson S, et al. Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy. Cell Cycle. 2009;8(14):2260–2265.
- C W Z, Z H C, X J Z, et al. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. Autophagy. 2014;10(10):1726–1737.
- Watts G. WHO annual report finds world at a crossroad on tuberculosis. BMJ. 2012;345:e7051.
- D G R, C E B 3rd, Flynn JL. Tuberculosis: what we don’t know can, and does, hurt us. Science. 2010;328(5980):852–856.
- Sotgiu G, Centis R, D’Ambrosio L, et al. Do we need a new Fleming epoque: the nightmare of drug-resistant tuberculosis. Int J Mycobacteriol. 2013;2(3):123–125.
- Keane J, M K B-S, H G R, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun. 1997;65(1):298–304.
- Xi X, Zhang C, Han W, et al. MicroRNA-223 is upregulated in active tuberculosis patients and inhibits apoptosis of macrophages by targeting FOXO3. Genet Test Mol Biomarkers. 2015;19(12):650–656.
- Huang J, Jiao J, Xu W, et al. MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3. Mol Med Rep. 2015;12(5):7102–7108.
- Zhang G, Liu X, Wang W, et al. Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages. Cell Cycle. 2016;15(18):2527–2538.
- Hui L, Zhang J, Guo X. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2. Biomed Pharmacother. 2018;103:1194–1201.
- Yang D, Zhan M, Chen T, et al. miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer. Sci Rep. 2017;7:43109.
- Zhu Y, Zhang S, Li Z, et al. miR-125b-5p and miR-99a-5p downregulate human gammadelta T-cell activation and cytotoxicity. Cell Mol Immunol. 2018;16:112–125.
- Z H C, W T W, Huang W, et al. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death Differ. 2017;24(2):212–224.
- J K K, H M L, K S P, et al. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2. Autophagy. 2017;13(2):423–441.
- Bai S, Tian B, Li A, et al. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma. Eye (Lond). 2016;30(12):1630–1638.